Responding to a question in the Commons from shadow science secretary Alan Mak, Sir Chris said AstraZeneca reduced its contribution and the deal “simply didn’t add up for the UK taxpayer”.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback